This course has expired. View available courses.
Oncology
Optimising outcomes with sunitinib for metastatic renal cell carcinoma (mRCC): focus on anticipating and managing adverse effects – Certificate of Completion
DURATION
PROFESSION
Specialist
# OF CREDITS
2
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2018-09-12
Learning objectives
On completion of this program, participants will be better able to:
- Describe current metastatic renal cell carcinoma (mRCC) treatment options and sunitinib management practices
- Manage toxicities of sunitinib treatment and interpret their possible prognostic value
- Recognise the benefits of a multi-disciplinary team approach when treating a patient with RCC
- Recall second-line treatment options and the current data supporting these options